Home/Filings/4/0001555667-13-000047
4//SEC Filing

SOLAZYME INC 4

Accession 0001555667-13-000047

CIK 0001311230operating

Filed

Aug 11, 8:00 PM ET

Accepted

Aug 12, 8:34 PM ET

Size

8.9 KB

Accession

0001555667-13-000047

Insider Transaction Report

Form 4
Period: 2013-08-09
Rotsaert Jean-Marc
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    2013-08-09$12.62/sh7,000$88,31991,000 total
  • Exercise/Conversion

    Common Stock

    2013-08-09$8.35/sh+7,000$58,45098,000 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2013-08-097,00043,000 total
    Exercise: $8.35Exp: 2023-02-24Common Stock (7,000 underlying)
Footnotes (3)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.47 to $12.97, inclusive. The reporting person undertakes to provide to Solazyme, Inc., any security holder of Solazyme, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F3]The option vests as to 1/48 of the underlying shares monthly from January 1, 2013.

Issuer

SOLAZYME INC

CIK 0001311230

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001311230

Filing Metadata

Form type
4
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 8:34 PM ET
Size
8.9 KB